Seeking Alpha
 

Obagi Medical Products, Inc. (OMPI)

- NASDAQ
OMPI is defunct.
  • Apr. 8, 2013, 9:10 AM
    Premarket gainers: LUFK +38%. BSDM +34%. BCRX +18%. UNXL +15%. GOL +10%. TSL +7%.
    Losers: OMPI -6%. DCTH -5%.
    | Comment!
  • Apr. 8, 2013, 8:18 AM
    Obagi Medical (OMPI) falls before the bell after German drug maker Merz says it will not up the ante on Valeant Pharmaceuticals (VRX) in what was set to become a bidding war for OMPI. Merz, which called itself "a disciplined buyer" this morning, topped Valeant's original $19 per share offer last week, but will now yield to Valeant's sweetened offer of $24. OMPI shares -5.6% premarket.
    | Comment!
  • Apr. 3, 2013, 9:10 AM
    Premarket gainers: CALL +14%. CONN +10%. ZNGA +10%. ASTX +10%. UNXL +9%. AWRE +9%. OMPI +9%. NVAX +9%. ALXA +8%. MHR +7%. NFX +6%.
    Losers: MSPD -19%. GPN -7%.
    | 3 Comments
  • Apr. 3, 2013, 8:12 AM
    Bidding war on: Valeant Pharmaceuticals (VRX) increases its offer for Obagi Medical (OMPI) to $24 a share in cash, a day after Merz Pharmaceuticals proposed $22. That bid had trumped Valeant's original offer of $19.75. Obagi has accepted Valeant's new proposal, which has sent the former's shares up 8.4% to $24.80.
    | Comment!
  • Apr. 2, 2013, 9:10 AM
    Premarket gainers: BGCP +47%. OMPI +14%. HUM +10%. NUAN +9%. URBN +6%.
    Losers: NAT -12%. AFFY -7%.
    | Comment!
  • Apr. 2, 2013, 8:12 AM
    Merz Pharmaceuticals offers $22 a share for Obagi (OMPI) and trumps Valeant's (VRX) bid of $19.75 , which valued Obagi at $360M. Merz says it has the money to pay for the deal and doesn't need to carry out further due diligence, as it was already in talks to buy Obagi when the Valeant deal was announced. Obagi surges 15.2% to $22.70.
    | 2 Comments
  • Mar. 20, 2013, 12:45 PM
    Midday top 10 gainers: OMPI +28%. AFFY +18%. MTSL +13%. NPD +12%. CHYR + 12%. GEVO +12%. WSM +11%. BIOF +10%. AIR +9%. PPHM +8%.
    Midday top 10 losers: ATOS -18%. LIVE -15%. MXWL -15%. CHKR -14%. ECT -12%. CIG -13%. SGOC -12%. FFEX -11%. ABCD -11%. OTIV -9%.
    | Comment!
  • Mar. 20, 2013, 9:10 AM
    Premarket gainers: OMPI +28%. GEVO +17%. CIE +7%. WSM +6%. ADBE +6%. BBRY +5%.
    Losers: ECT -9%. CIG -9%.
    | 7 Comments
  • Mar. 15, 2013, 11:39 AM
    Obagi Medical (OMPI +7.7%) moves up today after topping Q4 estimates late yesterday. Looking forward, the company sees FY13 earnings of $0.80 to $0.84 per share on $126M to $130M. The Street is at $0.88 per share and $128.31M in revenue. Cantor Fitzgerald upgraded the shares to Buy on the back of the report and raised its price target from $15.00 to $19.00, noting a 50% probability of a takeout in the $21 range.
    | 1 Comment
  • Aug. 7, 2012, 9:33 AM
    Avon (AVP) has held serious talks about acquiring Obagi Medical Products (OMPI), although it hasn't yet bid high enough, writes SA author Scott Matusow, while L'Oreal (LRLCY.PK) is also showing interest. Matusow reckons that with institutions owning about 90% of the company, and with "the majority of them" wanting Obagi sold," a deal will happen soon.
    | Comment!
  • Aug. 2, 2012, 6:18 PM
    Obagi Medical Products (OMPI): Q2 EPS of $0.22 beats by $0.02. Revenue of $30.5M (+5.6% Y/Y) in-line. Shares -4.7% AH. (PR)
    | Comment!
  • Jul. 11, 2012, 9:10 AM
    Premarket gainers: OMPI +8%. OREX +7%.
    Losers: HGG -30%. OCZ -20%. PSEC -7%. KOF -6%. GG -6%. BBY -6%.
    | Comment!
  • Jul. 5, 2012, 11:07 AM
    Avon Products (AVP +2.4%) moves higher this morning on a report that it's filed a form 8k with the SEC in regards to taking out a line of credit for up to $750M dollars, with access to $500M immediately. SA contributor Scott Matusow says the company already has enough cash on hand for day-to-day operations, and thinks it may be on the hunt for an acquisition. One potential target: Obagi Medical Devices (OMPI +3.3%).
    | Comment!
  • Feb. 13, 2012, 1:54 PM
    Obagi Medical (OMPI +3.6%) trades higher on positive comments out of Cantor this morning. The firm says that recent data points from Allergan (AGN +1%) and Estee Lauder (EL -1.4%) support its view that the skin care products manufacturer will beat Q4 EPS estimates.
    | Comment!
  • May. 6, 2011, 9:00 AM
    Premarket gainers: DMD +17%. RBS +7%. LLNW +5%. SIFY +5%. ARMH +5%. TTM +5%. PWER +4%. MCP +3%. MTL +3%. SINA +3%. BHP +3%. MG +3%.
    Losers: OMPI -30%. CTIC -10%. BRE -4%. ABAT -4%. ALU -4%. ARE -4%. SD -3%. TITN -3%. ASX -3%.
    | 1 Comment
Visit Seeking Alpha's
Company Description
The Company was founded as WorldWide Product Distribution, Inc. (“Worldwide”) in 1988. OMP Acquisition Corporation was incorporated in California in October 1997 to purchase substantially all of the assets and to assume the accounts payable and related operating liabilities of WorldWide and... More
Sector: Healthcare
Industry: Biotechnology
Country: United States